NKp30+ NK cells contribute to HBV control during Pegylated-interferon-alfa-2b therapy of chronic hep

来源 :中国免疫学会第十届全国免疫学学术大会 | 被引量 : 0次 | 上传用户:jc422177405
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Approximately 400 million people are chronic HBV surface antigen carriers.There is a pressing need to improve therapeutic options for chronic hepatitis B.Pegylated interferon alpha (Peg-IFN-α) achieves sustained off-treatment responses in more cases than other existing treatments because of its direct anti-viruses effect and regulation of immunity.
其他文献
Objective: Protein kinase C (PRKC) is a family of serine/threonine kinases, and these PRKC isozymes have crucial roles in diverse cellular signaling processes including cellular proliferation, differe
目的:检测肺癌患者血清21种细胞因子的表达水平,分析其与肺癌临床病理特征的关系及各细胞因子间的相关性.方法:采用液相芯片技术检测经病理确诊但未治的40例肺癌患者及30例正常人血清中IL-2、IFN-γ、TNF-α、IL-12、IL-4、IL-5、IL-6、IL-10、IL-13、IL-17A、IL-8、ITAC、Fractalkine、MIP-3a、MIP-1a、 MIP1β、GM-CSF、IL-
Anisomycin, an antibiotic produced by Streptomyces, strongly induces apoptosis in different histological sorts of cancer cells in vitro, superior dramatically to adriamycin.
Transforming growth factor-beta (TGF-β) suppresses T cell function to promote tumor immune escape.The essential roles of B7-H3 and B7-H4 have been uncovered in inhibiting T cell function during anti-t
Background: The Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) has been reported to have both tumor-promoting and tumor-suppressing roles in tumorigenesis and tumor development.
在迎来肿瘤免疫治疗巨大机遇之时,我们必须保持清醒的头脑,客观的分析免疫治疗在肿瘤临床治疗中面临的挑战。肿瘤免疫治疗的复杂性 实体肿瘤的治疗是集手术、化疗、放疗、生物免疫治疗、中医药、心理治疗、营养代谢调整于一体的综合治疗。
Background and Purposes: Accumulating evidences implies that the neurotrophic factor and their receptors contribute to tumor progression.
目的:本研究旨在探究和揭示肺癌患者恶性胸腔积液(MPE)免疫微环境中T淋巴细胞功能受损的免疫机制,为其免疫治疗提供新的线索。方法:流式细胞术检测35例肺癌患者MPE中单个核细胞及其配对的外周血单个核细胞(PBMC)中CD4+和CD8+T细胞的抑制性分子(Tim-3,PD-1,CTLA-4)及其功能性细胞因子(IFN-γ,GranzymeB)的表达。
Aim: The epidemic Influenza A/H1N1 in 2009 causes severe morbidity and mortality mainly in elder and children population.
背景:肝移植是目前治疗终末期肝病最有效的治疗方式,近年来随着外科学、影像学尤其是免疫抑制剂的应用,移植受者生存率获得了显著提高。但长期的免疫抑制剂如他克莫司(FK506)的应用会带来许多严重的副作用如感染、肾毒性、代谢紊乱等。